Research output: Contribution to Journal/Magazine › Journal article › peer-review
Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - Living with age-related macular degeneration treatment
T2 - Patient experiences of being treated with ranibizumab (Lucentis) intravitreal injections
AU - Thetford, Clare
AU - Hodge, Suzanne
AU - Harding, Simon
AU - Taylor, Sandra
AU - Knox, Paul
PY - 2013/5
Y1 - 2013/5
N2 - This study reports the results of a qualitative study of patient experiences of receiving treatment for wet age-related macular degeneration with ranibizumab (Lucentis)(R). Treatment involved monthly hospital visits for assessment and, where required, an intravitreal Lucentis injection. Qualitative narrative interviews were conducted with 22 patients, 18 of whom received treatment and were interviewed at two points during their treatment journey. Interviews allowed participants to reflect on their experiences of being assessed for and receiving this treatment. Overall, treated participants reported that while they had been apprehensive about treatment, the actual experience of it was far less unpleasant than they had expected. However, the data also revealed a number of issues surrounding the provision of information about treatment, as well as service delivery issues, which had considerable impact upon their experience.
AB - This study reports the results of a qualitative study of patient experiences of receiving treatment for wet age-related macular degeneration with ranibizumab (Lucentis)(R). Treatment involved monthly hospital visits for assessment and, where required, an intravitreal Lucentis injection. Qualitative narrative interviews were conducted with 22 patients, 18 of whom received treatment and were interviewed at two points during their treatment journey. Interviews allowed participants to reflect on their experiences of being assessed for and receiving this treatment. Overall, treated participants reported that while they had been apprehensive about treatment, the actual experience of it was far less unpleasant than they had expected. However, the data also revealed a number of issues surrounding the provision of information about treatment, as well as service delivery issues, which had considerable impact upon their experience.
KW - Age-related macular degeneration
KW - intravitreal injection
KW - Lucentis
KW - patient experience
KW - ranibizumab
KW - service delivery
KW - wet age-related macular degeneration
U2 - 10.1177/0264619613481778
DO - 10.1177/0264619613481778
M3 - Journal article
VL - 31
SP - 89
EP - 101
JO - British Journal of Visual Impairment
JF - British Journal of Visual Impairment
SN - 0264-6196
IS - 2
ER -